Belgium COVID-19 initiative renews collaboration for molecular testing

Thomas Beuls | Press Release | 4/08/2020

Brussels, Belgium | August 3, 2020 | The Belgian government and UgenTec have agreed to extend their existing agreement to automate COVID PCR analysis for high-throughput laboratories. Multiple sites that are part of the national COVID testing hub, including the University of Liege and Biogazelle, were selected as molecular ‘overflow’ testing sites.

UgenTec and the Belgian government today announced the extension of their collaboration on currently ongoing PCR data analysis automation projects for high-throughput SARS-CoV-2 laboratories. The sites of the University of Liege & Biogazelle have automated the data analysis of PCR results using UgenTec’s FastFinder Analysis solution.

In an effort to ramp up daily testing the Belgian government has set up a number of ultra-high throughput laboratory hubs. The laboratory sites of the University of Liege and Biogazelle all offer clinical-grade lab space as well as the required personnel and technical expertise to perform large numbers of PCR tests.

UgenTec’s FastFinder platform is a workflow and data analysis suite designed to support molecular laboratories’ scalability, standardization, traceability and compliance efforts. FastFinder software automates PCR data analysis, result and quality reporting. 

With volumes running as high as thousands of samples per day, we need reliable software to guarantee test turnaround time and monitor quality and performance” said Dr. Jo Vandesompele, at Biogazelle. “FastFinder takes away the pain of manual data review and ensures we have insights into essential metrics such as positive rates, assay performance, continuous test proficiency and QC tracking.”

During Belgium’s COVID-19 peak, we recorded up to 20.000 samples being processed with FastFinder in a single day.” said Steven Verhoeven, CEO at UgenTec. “With continued resurgence and localized outbreaks, high-volume testing will be with us for the foreseeable future. We’re proud to support these large scale laboratories and national initiatives with advanced data analysis and lab intelligence solutions to ensure the testing is highly robust and provides reliable answers in the context of massive sample throughput.”

Contact
UgenTec NV, Belgium
Thomas Beuls
Thomas.beuls@ugentec.com

UgenTec Inc, Cambridge MA, USA
Steven Van Vooren
Steven.VanVooren@ugentec.com

Info@ugentec.com

About UgenTec
UgenTec is a molecular laboratory software provider servicing molecular labs, assay and instrument providers globally across applications in Clinical Molecular Diagnostics, Veterinary health, Crop Science, Breeding and Seed Health. UgenTec is headquartered in Hasselt, Belgium with offices in Boston, MA and its FastFinder platform has a global installed base of over 100 molecular labs and partnerships with leading molecular diagnostics vendors.

FastFinder is a modular, clinical grade Software as a Service platform using AI methods allowing labs of all sizes to standardize and automate their molecular workflows. FastFinder’s modules include Analysis, Insights, Genotyper and Workflow.

Visit http://www.ugentec.com/ for more information.

Paris, France | Brussels, Belgium | August 27, 2020 | The centralized hospital procurement group UniHA and UgenTec have agreed on a FastFinder PCR sof...
Freiburg, Germany | Boston, MA | Today, Eurofins GeneScan Technologies GmbH and UgenTec, Inc. announce the successful NF VALIDATION certification of f...
Today, Eurofins GeneScan Technologies GmbH and UgenTec announced a collaboration on the development of assay plugins for Eurofins GeneScan Technologie...